Mobius Therapeutics, LLC Issues a Voluntary Recall of Mitosol® (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Mobius Therapeutics, LLC Issues a Voluntary Recall of Mitosol® (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use

01/10/2013 11:41 AM EST

On 10 January 2013, Mobius Therapeutics, LLC, St. Louis, MO, announced today that it is conducting a voluntary recall of 2 lots of Mitosol® (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use. The company is taking this voluntary action due to the fact that we cannot exclude the possibility that the affected lots may be non-sterile.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420